- Home
- BZFD vs APLT Comparison
BZFD vs APLT Comparison
Compare BZFD & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZFD
- APLT
- Stock Information
- Founded
- BZFD 2006
- APLT 2016
- Country
- BZFD United States
- APLT United States
- Employees
- BZFD N/A
- APLT N/A
- Industry
- BZFD Movies/Entertainment
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- BZFD Consumer Discretionary
- APLT Health Care
- Exchange
- BZFD Nasdaq
- APLT Nasdaq
- Market Cap
- BZFD 76.3M
- APLT 69.0M
- IPO Year
- BZFD N/A
- APLT 2019
- Fundamental
- Price
- BZFD $2.02
- APLT $0.51
- Analyst Decision
- BZFD
- APLT Buy
- Analyst Count
- BZFD 0
- APLT 6
- Target Price
- BZFD N/A
- APLT $6.10
- AVG Volume (30 Days)
- BZFD 334.8K
- APLT 893.4K
- Earning Date
- BZFD 08-07-2025
- APLT 08-13-2025
- Dividend Yield
- BZFD N/A
- APLT N/A
- EPS Growth
- BZFD N/A
- APLT N/A
- EPS
- BZFD 0.25
- APLT N/A
- Revenue
- BZFD $194,178,000.00
- APLT $121,000.00
- Revenue This Year
- BZFD $6.29
- APLT $415.60
- Revenue Next Year
- BZFD $6.16
- APLT $1,323.96
- P/E Ratio
- BZFD $7.77
- APLT N/A
- Revenue Growth
- BZFD 1.38
- APLT N/A
- 52 Week Low
- BZFD $1.61
- APLT $0.30
- 52 Week High
- BZFD $5.68
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- BZFD 45.55
- APLT 61.88
- Support Level
- BZFD $1.87
- APLT $0.47
- Resistance Level
- BZFD $2.14
- APLT $0.53
- Average True Range (ATR)
- BZFD 0.12
- APLT 0.03
- MACD
- BZFD -0.01
- APLT 0.00
- Stochastic Oscillator
- BZFD 44.77
- APLT 83.33
About BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.